GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Mouwasat Medical Services Company SJSC 4002.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

55.60

+1.09%

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

19 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 5Strong buy
  • 7Buy
  • 7Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 89.90

Low
76.76
Average
89.90
Median
87.41
High
109.20

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenueSAR 3.59bnSAR 3.92bnSAR 4.26bnSAR 4.83bnSAR 4.68bn
Revenue, highestSAR 3.71bnSAR 4.12bnSAR 4.45bnSAR 5.04bnSAR 4.89bn
Revenue, lowestSAR 3.52bnSAR 3.63bnSAR 4.06bnSAR 4.60bnSAR 4.46bn
Earnings per share4.204.454.875.465.80
Earnings per share, highest4.414.865.155.776.13
Earnings per share, lowest4.013.654.575.135.44
Analysts1111455

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast0.950.950.840.900.960.911.071.63
Reported0.941.041.020.751.000.930.990.86
Difference-0.5%+9.9%+21.4%-16.7%+4.3%+2.4%-7.1%-47.2%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

10 / 10

Revenue growth 12.4% a year over 10 years. Return on equity 21.8%.

Model fair value

100.66

From earnings 100.66, from revenue 98.61.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.